Search

Your search keyword '"Liver pathology"' showing total 97,396 results

Search Constraints

Start Over You searched for: Descriptor "Liver pathology" Remove constraint Descriptor: "Liver pathology"
97,396 results on '"Liver pathology"'

Search Results

1. Alcohol consumers with liver pathology rarely display α-synuclein pathology.

2. COVID-19-associated secondary sclerosing cholangitis with liver transplantation.

3. Clinical case: liver damage in a patient with coronavirus disease

4. Immune-Mediated Liver Effects Associated With Administration of a Human Anti-IL-21 Receptor Antibody (ATR-107) in Rats.

5. Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis.

6. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.

7. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults

8. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.

10. DUBİN-JOHNSON SİNDROMU ZAMANI HİPERBİLİRUBİNEMİYANIN İNKİŞAF MEXANİZMİNDƏ MRP2 MUTASİYALARININ PATOFİZİOLOJİ TƏDQİQİ.

11. Unraveling the complexities of fibrosis and ductular reaction in liver disease: pathogenesis, mechanisms, and therapeutic insights.

12. Erythrophagocytosis is not a reproducible finding in liver biopsies, and is not associated with clinical diagnosis of hemophagocytic lymphohistiocytosis.

13. Implementation of deep learning in liver pathology optimizes diagnosis of benign lesions and adenocarcinoma metastasis.

14. Label-Free Imaging Techniques to Evaluate Metabolic Changes Caused by Toxic Liver Injury in PCLS.

15. Effect of Hepatic Pathology on Liver Regeneration: The Main Metabolic Mechanisms Causing Impaired Hepatic Regeneration.

16. Pathology of liver tumours.

17. Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH)

19. Clinical and diagnostic characteristics of the development of hepatocardial syndrome in black and white cows in the early lactation period

20. Optical Biomedical Imaging Reveals Criteria for Violated Liver Regenerative Potential.

21. Implementation of deep learning in liver pathology optimizes diagnosis of benign lesions and adenocarcinoma metastasis

22. To the 90th anniversary of the birth of Nikolai Veniaminovich Kaverin

23. Multidrug resistant Enterococcus faecium isolate from cholangitis/cholecystitis in a dog

24. Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days.

25. Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH).

26. Assessment of Mouse Liver Histopathology Following Exposure to HFPO-DA With Emphasis on Understanding Mechanisms of Hepatocellular Death.

27. Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver Lipid Infiltration.

28. IL-33/ST2 Axis Deficiency Exacerbates Hepatic Pathology by Regulating Treg and Th17 Cells in Murine Schistosomiasis Japonica

29. Clinical and diagnostic characteristics of the development of hepatocardial syndrome in black and white cows in the early lactation period.

30. Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr-/-.Leiden mice.

31. MOR23 deficiency exacerbates hepatic steatosis in mice.

32. Extracellular matrix protein 1 binds to connective tissue growth factor against liver fibrosis and ductular reaction.

33. Practical approach to diagnose and manage benign liver masses.

34. The potential value of fatty acid binding protein 1 in Chronic HBV-related liver disease progression assessment.

35. VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway.

36. Therapeutic Potential of Lactiplantibacillus plantarum FB091 in Alleviating Alcohol-Induced Liver Disease through Gut-Liver Axis.

37. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid.

38. Morinda officinalis iridoid glycosides alleviate methotrexate-induced liver injury in CIA rats by increasing liver autophagy and improving lipid metabolism homeostasis.

39. Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling.

40. Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy.

41. Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress.

42. Exosomes derived from apical papilla stem cells improve NASH by regulating fatty acid metabolism and reducing inflammation.

43. Regulation of hepatic inclusions and fibrinogen biogenesis by SEL1L-HRD1 ERAD.

44. Molecular alterations associated with pathophysiology in liver-specific ZO-1 and ZO-2 knockout mice.

45. Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring.

46. Nucleos(t)ide analogues potentially activate T lymphocytes through inducing interferon expression in hepatic cells and patients with chronic hepatitis B.

47. Formononetin attenuates hepatic injury in diabetic mice by regulating macrophage polarization through the PTP1B/STAT6 axis.

48. Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT/NF-κB signaling pathway.

49. DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis.

50. MRG15 aggravates sepsis-related liver injury by promoting PCSK9 synthesis and secretion.

Catalog

Books, media, physical & digital resources